This newly identified mechanism helps provide a better understanding of carcinogenesis, and the ADV-MLH1 adenovirus vector may serve as a novel potential therapeutic treatment for human endometrial carcinoma. The gene discussed is MLH1; the disease is endometrial carcinoma.